產(chǎn)品名稱 MK 0822 - Odanacatib
產(chǎn)品貨號(hào) Axon 1771 CAS [603139-19-1] MF C25H27F4N3O3SMW 525.56 Purity: 99% Optical purity: Optically pure Soluble in DMSO Description Potent and selective inhibitor of cathepsin K (CTSK or Cat K) References Certificates Categories Extra info CL Le Gall et al. Cathepsin K inhibitors as treatment of bone metastasis. Curr. Opin. Support. Palliat. Care. 2008, 2(3), 218. ? JY Gauthier et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg. Med. Chem. Lett. 2008, 18(3), 923–928. ? EM Lewiecki. Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling. IDrugs. 2009, 12(12), 799-809. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Miscellaneous Cathepsin-K EC 3.4.22.8 Inhibitor of cathepsin K Chemical name (S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)pentanamide Parent CAS No. [603139-19-1] Order Size Unit Price Stock 2 mg €80.00 In Stock
產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
產(chǎn)品規(guī)格
產(chǎn)品品牌 axonmedchem
產(chǎn)品概述
產(chǎn)品詳情

MK 0822 - Odanacatib

Based on 15 reference(s) in Google Scholar 8 10 15

Axon 1771

CAS [603139-19-1]

MF C25H27F4N3O3S
MW 525.56

  • Purity: 99%
  • Optical purity: Optically pure
  • Soluble in DMSO

MK 0822

Description

Potent and selective inhibitor of cathepsin K (CTSK or Cat K)
產(chǎn)品資料